532331 Stock Overview
A specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Ajanta Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,950.55 |
| 52 Week High | ₹3,485.75 |
| 52 Week Low | ₹1,852.55 |
| Beta | 0.10 |
| 11 Month Change | -0.92% |
| 3 Month Change | -4.92% |
| 1 Year Change | 50.14% |
| 33 Year Change | 111.96% |
| 5 Year Change | 343.05% |
| Change since IPO | 18,340.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532331 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.2% | -0.5% | -1.2% |
| 1Y | 50.1% | 41.6% | 25.5% |
Return vs Industry: 532331 exceeded the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 532331 exceeded the Indian Market which returned 27.3% over the past year.
Price Volatility
| 532331 volatility | |
|---|---|
| 532331 Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 532331 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 532331's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 8,073 | Yogesh Agrawal | www.ajantapharma.com |
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas. It also provides tablets, capsules, injectables, inhalers, ointments, creams, and liquids.
Ajanta Pharma Limited Fundamentals Summary
| 532331 fundamental statistics | |
|---|---|
| Market cap | ₹367.86b |
| Earnings (TTM) | ₹8.75b |
| Revenue (TTM) | ₹44.91b |
42.0x
P/E Ratio8.2x
P/S RatioIs 532331 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532331 income statement (TTM) | |
|---|---|
| Revenue | ₹44.91b |
| Cost of Revenue | ₹11.43b |
| Gross Profit | ₹33.48b |
| Other Expenses | ₹24.73b |
| Earnings | ₹8.75b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 70.06 |
| Gross Margin | 74.56% |
| Net Profit Margin | 19.48% |
| Debt/Equity Ratio | 0.07% |
How did 532331 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield78%
Payout RatioDoes 532331 pay a reliable dividends?
See 532331 dividend history and benchmarks| Ajanta Pharma dividend dates | |
|---|---|
| Ex Dividend Date | Nov 06 2024 |
| Dividend Pay Date | Nov 27 2024 |
| Days until Ex dividend | 16 days |
| Days until Dividend pay date | 5 days |
Does 532331 pay a reliable dividends?
See 532331 dividend history and benchmarks